 | • レポートコード：B-MOR-040399 • 出版社/出版日：Mordor Intelligence / 2018年3月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・バイオ |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、デジタル治療装置の世界市場について調べ、デジタル治療装置の世界規模、市場動向、市場環境、製品別（疼痛管理装置、リハビリ装置、呼吸療法装置、インスリンポンプ）分析、用途別（予防、治療・ケア）分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・デジタル治療装置の世界市場インサイト ・デジタル治療装置の世界市場環境 ・デジタル治療装置の世界市場動向 ・デジタル治療装置の世界市場規模 ・デジタル治療装置の世界市場規模：製品別（疼痛管理装置、リハビリ装置、呼吸療法装置、インスリンポンプ） ・デジタル治療装置の世界市場規模：用途別（予防、治療・ケア） ・デジタル治療装置の世界市場規模：エンドユーザー別 ・デジタル治療装置の世界市場：地域別市場規模・分析 ・デジタル治療装置の北米市場規模・予測 ・デジタル治療装置のアメリカ市場規模・予測 ・デジタル治療装置のヨーロッパ市場規模・予測 ・デジタル治療装置のアジア市場規模・予測 ・デジタル治療装置の日本市場規模・予測 ・デジタル治療装置の中国市場規模・予測 ・デジタル治療装置のインド市場規模・予測 ・デジタル治療装置の韓国市場規模・予測 ・関連企業情報・競争状況 |
The global digital therapeutic devices market is expected to register a CAGR of around 14.2% during the forecast period, 2018 to 2023. North America is expected to dominate this market due to rise in the early adoption of new technologies and increased fund investments. Further, Asia-Pacific is expected to grow at a higher rate as compared to other regions.
Rise in Technological Advancements
There has been a rise in the use of technology for therapeutics toward medical conditions. The consumers in developed markets are increasingly aware of the advanced products for treatment of medical conditions. Particularly, due to rise in disposable incomes, which enables them to adopt these products. The preference is also, therefore, shifted toward the advanced services in the medical field including the growing demand for innovations in therapeutic devices. Example, C2 CryoBalloon Ablation System developed by C2 Therapeutics uses cryosurgical tool in general surgery, mild devices developed by Vertos Medical is a safe, minimally invasive treatments for lumbar spinal stenosis, which does not require anesthesia, implants or stiches.
Along with this factor, the increased focus toward preventive healthcare by the government is also one of the major driving factors. The government is taking initiatives and launching programs for higher adoption rate of these devices, shifting from traditional healthcare practices. The companies are also increasingly rising on venture investments in this domain, which drives this market, such as USD 20 million investment by Pear Therapeutics on substance abuse issues. The rising prevalence of chronic diseases, such as diabetes (1.6 million deaths in 2015) and cardiovascular diseases (an estimated 17.7 million deaths each year) drive the growth of the digital therapeutic devices market.
Concerns Related to Privacy of Patients’ Data
Factors, such as patient’s data privacy concerns associated with digital therapeutic devices, hinder the growth of this market. When the information is transferred to the connected devices and sensors, it reaches into the Internet of Things territory. Since healthcare involves huge data related to patients and companies, cybersecurity is a major issue with increasing levels of connectivity between hospital chains, providers, and payers. As the information is continuously being monitored by doctors, such as the use of Bluetooth-enabled blood pressure cuffs and weight scales, the privacy concerns further rise. Other factors hindering the growth of this market include high cost of manufacturing and installation and resistance of public to traditional healthcare providers. All these factors impede the growth of the digital therapeutics devices market.
North America to Dominate the Market
The digital therapeutics devices market is segmented by product type, application, end user, and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.
North America is expected to dominate the market, owing to the early adoption of new technologies and rising investment through funding in this region. The funding is associated with rising investment from government, venture capitalists, mergers, and acquisitions. Example: Recent approval of Abilify MyCite in the United States has attracted investments from several large healthcare companies, such as Novartis AG, Medtronic Inc., and Otsuka Pharmaceuticals, among others. In addition, Asia-Pacific is expected to show a high growth rate due to large population size, increasing penetration of smartphones, and rising government initiatives.
Key Developments in the Market
• January 2018: Voluntis and WellDoc announced a commercial agreement to develop holistic digital diabetes management solution for healthcare system, patients, and providers
• September 2017: Pear Therapeutics’ reSET system granted a de novo clearance by the FDA for the treatment of substance abuse.
Major Players: BIOTELEMETRY INC., CANARY HEALTH, LIVONGO HEALTH, PEAR THERAPEUTICS, INC., PROPELLER HEALTH, PROTEUS DIGITAL HEALTH, NANOBIOSYM, INC., TWINE HEALTH, INC., WELLDOC INC., AND ZEST HEALTH, among others.
Reasons to Purchase this Report
• Current and future of digital therapeutics devices market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rising Incidences of Chronic Diseases
6.1.2 Rise in Technological Adavancements
6.1.3 Increasing Focus Toward Preventive Healthcare by Government
6.1.4 Rise in Venture Capital Investments
6.2 Market Restraints
6.2.1 High Cost of Manufacturing and Installation
6.2.2 Data Privacy Concerns
6.2.3 Resistance from Traditional Healthcare Providers
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product
7.1.1 Pain Management Devices
7.1.2 Rehabilitation Devices
7.1.3 Respiratory Therapy Devices
7.1.4 Insulin Pumps
7.2 By Application
7.2.1 Preventive
7.2.1.1 Pre-diabetes
7.2.1.2 Obesity
7.2.1.3 Smoking Cessation
7.2.1.4 Others
7.2.2 Treatment/Care
7.2.2.1 Cardiovascular Diseases
7.2.2.2 Central Nervous System Disease
7.2.2.3 Diabetes
7.2.2.4 Musculoskeletal Diseases
7.2.2.5 Respiratory Diseases
7.2.2.6 Others
7.3 By End User
7.3.1 Patients
7.3.2 Providers
7.3.3 Pharmaceutical Companies
7.3.4 Others
7.4 By Geography
7.4.1 North America
7.4.1.1 United States
7.4.1.2 Canada
7.4.1.3 Mexico
7.4.2 Europe
7.4.2.1 France
7.4.2.2 Germany
7.4.2.3 United Kingdom
7.4.2.4 Italy
7.4.2.5 Spain
7.4.2.6 Rest Of Europe
7.4.3 Asia-Pacific
7.4.3.1 China
7.4.3.2 Japan
7.4.3.3 India
7.4.3.4 Australia
7.4.3.5 South Korea
7.4.3.6 Rest of Asia-Pacific
7.4.4 Middle East & Africa
7.4.4.1 GCC
7.4.4.2 South Africa
7.4.4.3 Rest of the Middle East & Africa
7.4.5 South America
7.4.5.1 Brazil
7.4.5.2 Argentina
7.4.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 BioTelemetry Inc.
9.2 Canary Health
9.3 Livongo Health
9.4 Nanobiosym, Inc.
9.5 Pear Therapeutics, Inc.
9.6 Propeller Health
9.7 Proteus Digital Health
9.8 Twine Health, Inc.
9.9 WellDoc Inc.
9.10 Zest Health
9.11 Others
10. Future of the Market